RT Journal Article
SR Electronic
T1 Exposure contrasts of pregnant women during the Household Air Pollution Intervention Network randomized controlled trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.04.21265938
DO 10.1101/2021.11.04.21265938
A1 Johnson, Michael
A1 Pillarisetti, Ajay
A1 Piedrahita, Ricardo
A1 Balakrishnan, Kalpana
A1 Peel, Jennifer L.
A1 Steenland, Kyle
A1 Underhill, Lindsay J.
A1 Rosa, Ghislaine
A1 Kirby, Miles A.
A1 Díaz-Artiga, Anaité
A1 McCracken, John
A1 Clark, Maggie L.
A1 Waller, Lance
A1 Chang, Howard
A1 Wang, Jiantong
A1 Dusabimana, Ephrem
A1 Ndagijimana, Florien
A1 Sambandam, Sankar
A1 Mukhopadhyay, Krishnendu
A1 Kearns, Katherine
A1 Campbell, Devan
A1 Kremer, Jacob
A1 Rosenthal, Joshua
A1 Checkley, William
A1 Clasen, Thomas
A1 Naeher, Luke
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/11/05/2021.11.04.21265938.abstract
AB Background Exposure to PM2.5 arising from solid fuel combustion is estimated to result in approximately 2.3 million premature deaths and 90 million lost disability-adjusted life years annually. ‘Clean’ cooking interventions attempting to mitigate this burden have had limited success in reducing exposures to levels that may yield improved health outcomes.Objectives This paper reports exposure reductions achieved by a liquified petroleum gas (LPG) stove and fuel intervention for pregnant mothers in the Household Air Pollution Intervention Network (HAPIN) randomized controlled trial.Methods The HAPIN trial included 3,195 households primarily using biomass for cooking in Guatemala, India, Peru, and Rwanda. 24-hour exposures to PM2.5, carbon monoxide (CO), and black carbon (BC) were measured for pregnant women once before randomization into control (n=1605) and LPG arms (n=1590) and twice thereafter (aligned with trimester). Changes in exposure were estimated by directly comparing exposures between intervention and control arms and by using linear mixed-effect models to estimate the impact of the intervention on exposure levels.Results Median exposures of PM2.5, BC, and CO post-randomization in the intervention arm were lower by 66% (70.7 versus 24.0 μg/m3), 71% (9.6 versus 2.8 μg/m3), and 83% (1.2 versus ppm), respectively, compared to the control arm. Exposure reductions were similar across research locations. Post-intervention PM2.5 exposures in the intervention arm were at the lower end of what has been reported for LPG and other clean fuel interventions, with 69% of PM2.5 samples falling below the WHO Annual Interim Target 1 of 35 μg/m3.Discussion This study indicates that an LPG intervention with high displacement of traditional cooking can reduce exposures to levels thought to be associated with health benefits. Success in reducing exposures was likely due to strong performance of, and high adherence to the intervention.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02944682Funding StatementThis study was funded by the U.S. National Institutes of Health [cooperative agreement 1UM1HL134590] in collaboration with the Bill & Melinda Gates Foundation [OPP1131279]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Nancy R Cook, Stephen Hecht, Catherine Karr (Chair), Joseph Millum, Nalini Sathiakumar, Paul K Whelton, Gail G Weinmann (Executive Secretary). Program Coordination: Gail Rodgers, Bill & Melinda Gates Foundation; Claudia L Thompson, National Institute of Environmental Health Science; Mark J. Parascandola, National Cancer Institute; Marion Koso-Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Joshua P Rosenthal, Fogarty International Center; Conception R Nierras, NIH Office of Strategic Coordination Common Fund; Katherine Kavounis, Dong- Yun Kim, Antonello Punturieri, and Barry S Schmetter, NHLBI. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. National Institutes of Health or Department of Health and Human Services or the Bill and Melinda Gates Foundation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol has been reviewed and approved by institutional review boards (IRBs) or Ethics Committees at Emory University (00089799), Johns Hopkins University (00007403), Sri Ramachandra Institute of Higher Education and Research (IEC-N1/16/JUL/54/49) and the Indian Council of Medical Research - Health Ministry Screening Committee (5/8/4-30/(Env)/Indo-US/2016-NCD-I), Universidad del Valle de Guatemala (146-08-2016) and Guatemalan Ministry of Health National Ethics Committee (11-2016), Asociacion Benefica PRISMA (CE2981.17), the London School of Hygiene and Tropical Medicine (11664-5) and the Rwandan National Ethics Committee (No.357/RNEC/2018), and Washington University in St. Louis (201611159). The study has been registered with ClinicalTrials.gov (Identifier NCT02944682).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors after completion of the trial.